-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0359_10-15-2010.pdf
January 01, 2010 - Outcome(s): Diagnostic accuracy, time to diagnosis, patient-oriented outcomes (e.g.,
delay of disease … Population(s): Patients with multiple sclerosis or clinically isolated syndrome
Intervention(s): Disease-modifying … improved function, alleviation of
spasticity, prevention of complications, quality of life, delay of disease … MS is a chronic, autoimmune disease of the central nervous system that can cause significant … ; treatments aim to reduce the frequency and
hasten recovery from relapses and exacerbations, slow disease
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0095_04-10-2009.pdf
January 01, 2009 - Results of Topic Selection Process & Next Steps
Noninvasive diagnosis of coronary artery disease … )
Cardiovascular disease is the leading cause of mortality for women in the US. … The literature suggests
that compared to men, women present with more advanced disease due to the lack … Results of Systematic Review of Research on Diagnosis and
Treatment of Coronary Heart Disease in Women … Diagnosis and Treatment of Coronary Heart Disease in Women:
Systematic Reviews of Evidence on Selected
-
effectivehealthcare.ahrq.gov/sites/default/files/interactive_media_epstein_respondent.pdf
January 01, 2009 -
Slide
3:
What
are
the
“patient-‐centered”
goals
of
IM-‐supported
disease … consensual
decision-‐
making
Slide
4:
To
what
degree
does
IM-‐supported
disease … patient
can
interpret
and
infer
• Tailored
information
o Tailored
to
disease … Slide
17:
From
disease
management
to
patient/family-‐focused
health
enhancement … Slide
18:
Extensions
• How
can
the
lessons
from
chronic
disease
management
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
January 01, 2011 - Diabetes Rate
in Enrolled
Population
Total All 2006 32.8 8.7 26.4%
Age
Disabled/end stage
renal disease … Alaska Native
2006 0.1 0.1 36.0%
Total All 2007 32.3 8.8 27.3%
Age Disabled/end stage
renal disease … Alaska Native
2007 0.2 0.1 37.3%
Total All 2008 31.9 8.9 27.9%
Age Disabled/end stage
renal disease … Alaska Native
2006 9.7% 28.4% 6.4%
Total All 2007 8.1% 18.9% 5.0%
Age Disabled/end stage
renal disease … Without Diabetes and
Without PAD
Total All 2006 3.3% 11.0% 2.5%
Age Disabled/end stage
renal disease
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
January 01, 2024 - ≤60 ng/mL, WHO performance 0 to 2 Previous pelvis irradiation, radical prostatectomy, pelvic nodal disease … Gleason <= 6, and PSA <= 20 ng/mL; or T1 to 2, Gleason = 7, and PSA <= 20 ng/mL) without evidence of disease … Single Eligible patients included men with biopsy-confirmed prostate adenocarcinoma with high risk disease … All patients with high-risk disease were prescribed ADT for 2 years. … stenosis, colorectal surgery, repeated endoscopic examinations, interventions related to anorectal diseases
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-health-equity-preventive-services-comments.pdf
December 03, 2019 - Correct, the scope of the review is limited to 10
preventive services for cancer, cardiovascular disease … backgrounds are receiving evidence-
based preventive services for individuals with
cardiovascular diseases … Julia Charles:
Centers for
Disease Control
and Prevention
In particular, subject matter experts … members of these populations to quit smoking and thereby
reduce their risk of developing smoking-related diseases … Julia Charles:
Centers for
Disease Control
and Prevention
Including studies and related analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
January 01, 2024 - participants
● Participants who are pre- or post-bariatric
surgery
● Participants with other chronic diseases … (e.g., cancer, gastrointestinal disease,
rheumatic disease, chronic kidney
disease, neurologic diseases … (e.g., history
of myocardial infarction, angina, stroke,
arrhythmia), including congenital heart
diseases … Substitution of Dairy Products and
Risk of Death and Cardiometabolic Diseases: A Systematic Review and … Omega-3 Fatty Acids and Cardiovascular Disease:
An Updated Systematic Review.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
January 01, 2024 - participants
● Participants who are pre- or post-bariatric
surgery
● Participants with other chronic diseases … (e.g., cancer, gastrointestinal disease,
rheumatic disease, chronic kidney
disease, neurologic diseases … (e.g., history
of myocardial infarction, angina, stroke,
arrhythmia), including congenital heart
diseases … Red meat intake and risk of coronary heart disease
among US men: prospective cohort study. … Substitution of Dairy Products and
Risk of Death and Cardiometabolic Diseases: A Systematic Review and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diagnostic-error-executive-summary.pdf
August 01, 2023 - Stroke, the
top serious harm-producing disease, is missed an estimated 17% of the time. … Among these 15 diseases, myocardial infarction is the only one with false
negative rates near zero ( … 1.5%), well below the estimated average rate across all
diseases (5.7%) … • For a given disease, nonspecific or atypical symptoms increase the likelihood of
error. … Grouped
by organ system, neurologic diseases were the top category (34%).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
February 25, 2014 - Studies that compared
Crohn’s disease patients to
patients without inflammatory
bowel disease were … instrument for adult
patients with inflammatory bowel
disease. … Public: UCB Results, KQ2 Crohn’s disease is a chronic inflammatory bowel disease with a relapsing and … Smith, MD
Abbreviations CDAI = Crohn’s disease activity index IBD = inflammatory bowel disease Thank … The incidence/prevalence is much smaller than other
chronic diseases such as rheumatoid arthritis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - See Appendix B for a list of conclusions by Key Question and disease and
Appendix C for diseases where … Here, we focused on one
intervention and multiple diseases and disease indications, presenting a challenge … Although the diseases may appear to be similar, the implications of both the disease
and treatment on … Diseases
that have both rapidly and slowly progressive forms of disease where outcomes are overall … "[Mesh]) OR "Lysosomal
Storage Diseases"[Mesh]) OR "Glycogen Storage Disease"[Mesh]) OR "Niemann-Pick
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
December 01, 2023 - The Office of Disease
Prevention anticipated that the risk of postpartum maternal morbidity and mortality … stemmed from the fact that a number of states have added violence-
related questions to the Center for Disease … percent by comorbidities
(including prepregnancy body mass index, diabetes, hypertension, cardiac disease … , renal
disease, pulmonary disease, musculoskeletal disease, blood disorders, mental disorders, … 4
central nervous system disorders, rheumatic heart disease, anemia, and asthma).6 Finally,
if rural
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
April 01, 2015 - Analytic framework for discontinuing disease-modifying treatments for MS
DMT = disease-modifying treatment … and disease activity
after interrupting treatment. … stages of the disease, when
the side effects are less than disease symptoms. … course to prevent or delay
disease progression. … We cannot
currently predict early or benign disease courses.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
January 01, 2011 - Date: 3-23-11
1
Results of Topic Selection Process & Next Steps
Peripheral artery disease … intervention, and bypass surgery for improving health
outcomes for patients with peripheral artery disease … Staff-Generated PICO
Population(s): Adult patients with PAD and comorbid or multimorbid disease
Intervention … endovascular intervention (PTA, stents) more effective than exercise therapy in
Peripheral Artery Disease … )
PAD is a prevalent disease associated with an increased risk of cardiovascular events.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
May 01, 2021 - vaccines are effective in
controlling the spread of and even eradicating a variety of infectious diseases … The list of vaccines is based on the Centers for Disease Control and
Prevention’s (CDC) recommended … , autoimmune
thyroiditis (Hashimoto’s disease)
Note: No evidence of increased risk indicates that … Centers for Disease Control and Prevention.
Immunization Schedules: Table 1. … Centers for Disease Control and Prevention.
Immunization Schedules: Table 1.
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
January 01, 2011 - Beneficiaries, 2006-2008, by Age, Gender, and Race, and Broken Down by Diagnosis of
Peripheral Artery Disease … Alaska
Native
2006 6.9% 17.9% 5.0%
Total All 2007 6.0% 13.2% 4.0%
Age Disabled/end stage
renal disease … Alaska
Native
2007 6.8% 17.5% 4.9%
Total All 2008 6.0% 13.1% 3.9%
Age Disabled/end stage
renal disease … With Diabetes and
Without PAD
Total All 2006 0.5% 2.1% 0.053%
Age Disabled/end stage
renal disease … 2.08% 2.07% 1.93% 1.55%
Total All 2008 1.70% 1.78% 1.70% 1.43%
Age† Disabled/end stage renal
disease
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
August 01, 2024 - doublet
chemoradiation (CRT) with 5-fluorouracil (5FU) plus mitomycin (MMC) likely
results in greater disease-free … • Compared with concurrent CRT with 5FU, CRT with 5FU plus MMC may result
in greater disease-free … with capecitabine plus
MMC, CRT with paclitaxel plus capecitabine plus MMC showed greater overall, disease … Moderate
Disease-specific
mortality (up to 5
yrs)
1; RCT; n=585 CRT favored over RT alone; rate … Low
Disease-free
survival (up to 3
yrs)
1; RCT; n=144 Significantly greater in the paclitaxel arm
-
effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
December 01, 2009 - Mortality risk in chronic obstructive pulmonary disease
patients using theophylline. … disease (PUD), gastroesophogeal reflux disease (GERD),
arrhythmias, depression, hypertension, ischemic … A 4-year
trial of tiotropium in chronic obstructive
pulmonary disease. … The use of theophylline in
chronic obstructive pulmonary disease. … Chronic obstructive
pulmonary disease: a novel risk factor for
cardiovascular disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
December 01, 2009 - Mortality risk in chronic obstructive pulmonary disease
patients using theophylline. … disease (PUD), gastroesophogeal reflux disease (GERD),
arrhythmias, depression, hypertension, ischemic … A 4-year
trial of tiotropium in chronic obstructive
pulmonary disease. … The use of theophylline in
chronic obstructive pulmonary disease. … Chronic obstructive
pulmonary disease: a novel risk factor for
cardiovascular disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
August 01, 2012 - monitoring.8,11 The SFLC
assay may also be the only means of detecting a disease
marker in some disease … disease settings, and their results need
to be evaluated with this in mind. … as well as different disease
populations. … Finally, variation in disease severity studied
can lead to spectrum bias. … of disease
(e.g., response to treatment, relapse, or light chain escape).